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Abstract
Introduction Twenty-five years ago, the World Health Organization (WHO) published the Guide to Good Prescribing (GGP),
followed by the accompanying Teacher’s Guide to Good Prescribing (TGGP). The GGP is based on a normative 6-stepmodel for
therapeutic reasoning and prescribing, and provides a six-step guide for students to the process of rational prescribing.
Method We reviewed the need to update both WHO publications by evaluating their use and impact, including new (theoretical)
insights and demands. Based on information from literature, Internet, and other (personal) sources, we draw the following conclusions.
Results 1. An update of the GGP and TGGP, both in terms of content and form, is necessary because of the current need for these
tools (irrational medicine use and unavailability of medicines), the lack of similar documents, and the lack of connection with
recent developments, such as Internet and modern education; 2. The basic (6-step) model of the GGP is effective in terms of
rational prescribing in the undergraduate situation and is still consistent with current theories about (context) learning, clinical
decision-making, and clinical practice; 3. The dissemination and introduction of the GGP and TGGP in education has been
successful so far, but is still not optimal because of lack of support and cooperation.
Conclusions On the basis of the evaluation results, a plan for the revision of the GGP and TGGP is presented.
Keywords Guide togoodprescribing .WHO6step .Rationalprescribing .Pharmacotherapy .Education .Clinicalpharmacology
Introduction
(Quo vadis) Where are you going?
Due to a perceived need for improving prescribing practices,
theWorld Health Organization (WHO) published the Guide to
Good Prescribing (GGP) in 1994, followed by the
accompanying Teacher’s Guide to Good Prescribing
(TGGP) in 2001 [1, 2]. The GGP is based on a 6-step model
for rational prescribing (Table 1) and is primarily intended for
undergraduate students and their teachers. A more detailed
description and history of origin of both the original GGP
and TGGP can be found in box 1 as part of the online supple-
mentary materials of this article [3]. Both the GGP and TGGP
can be downloaded for free from the WHO website and the
GGP has been translated into 24 languages or local editions
(Table 2).
Since its publication in 1994, more than 100 original arti-
cles have referred to the GGP in a wide range of medical
journals, ranging from geriatrics, primary health care, internal
medicine, psychiatry, education to (clinical) pharmacology
and pharmacy. The latter category, namely, (clinical) pharma-
cology and pharmacy, accounts for more than half of the re-
ferring publications to the GGP.
Today, Good Prescribing guidance remains as necessary as
ever. In 2018, the WHO launched the Global Action Plan
(www.who.int/sdg/global-action-plan) which represents a
historic commitment by global health and development
agencies to advance collective action and accelerate progress
towards the health-related targets of the 2030 Agenda for
Sustainable Development. Sustainable development goal
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Target 3.8 is the achievement of universal health coverage
(UHC), including financial risk protection, access to quality
essential health care services, and access to safe, effective,
quality, and affordable essential medicines and vaccines for
all.
Central to access to safe and effective medicines is ensuring
that those prescribing the medicines have clear objectives and
can engage with their patients to obtain appropriate informa-
tion and hear their experience of their disease and treatment.
Prescribers can be a physician in a tertiary care center or phar-
macists and nurses in the frontline of primary care.
Furthermore the development of mobile technology now pro-
vides an unprecedented platform for both guidelines and train-
ing modules.
A group of experts from the WHO and Amsterdam
University Medical Centre recently discussed the need to up-
date the GGP and TGGP. They concluded that these valuable
guides should be updated, especially because of the lack of
alternative guidelines and the increasing global need for ratio-
nal medicine use [4]. They advised that the current use and
impact of these guides, including new (theoretical) insights
and demands, be evaluated first.
In this paper, we present the results of this evaluation,
which was based on a thorough literature and internet search,
and the use of other (personal) sources. It focused on the
impact of the GGP and TGGP on teaching and prescribing
skills and relevant new developments in the field. We close by
describing a project to determine what should be changed and
how appropriate changes should be made.
Impact on prescribing skills
Before the GGP was published, two randomized controlled
trials had shown that the problem-based teaching of the 6-
step method had a positive effect on prescribing skills and
knowledge. Medical students from seven universities from
all over the world were not only able to solve clinical prob-
lems that had been used during medical training (retention
effect), but could also use these skills and knowledge to solve
other clinical problems (transfer effect) [5, 6]. Thereafter mul-
tiple comparative studies (three randomized controlled trials,
three non-randomized comparative control, and two before-
and-after studies) reported similar effects of the 6-step method
on various aspects of rational prescribing by both medical
students and GPs in a wide range of countries [7].
Interestingly these positive results were also seen before and
after a 3-day course for nurses and paramedical prescribers in
South Africa when measuring WHO antibiotic prescribing
indicators in daily practice (MSc-dissertation; Hannelie
Meyer (med), School of Pharmacy Medunsa, South Africa,
1998). In a systematic review of educational interventions to
improve rational prescribing, published between 1990 and
2013, Kamarudin and co-workers found that the WHO 6-
step method had the largest body of supportive evidence as
method to improve rational prescribing [7]. Ross and co-
workers had reported similar findings in a systematic review
about 5 years earlier [8].
Impact on teaching
In the realization that the publication of the GGP would not be
effective in just spreading the word about rational prescribing,
the WHO started to support problem-based pharmacotherapy
training courses for teachers. They selected and paid for clin-
ical pharmacology/pharmacotherapy teachers from all WHO
regions to attend 2-week courses, the first six of which were
held at the WHO Collaborating Centre at the University of
Groningen in the Netherlands (1995–2000). After attending
these courses, participants were expected to organize similar
national or regional courses. At least seven such courses were
organized the period 1996–2001 in three different WHO
Regions (South Africa, Argentina, Indonesia and the
Philippines). In theWHO EasternMediterranean Region, sev-
eral advocacy training courses were held for university
teachers in Egypt, Jordan, the Gulf States, the Islamic
Republic of Iran, and Iraq. The WHO also provided support
for the translation of the GGP. There are currently 24
Table 2 Translations
and local editions of the















Table 1 WHO 6-step model for rational prescribing [1]
Step 1 Define the patient’s problem
Step 2 Specify the therapeutic objective
Step 3a Choose your standard treatment (p-drug)
Step 3b Verify the suitability of your treatment (p-drug)
Step 4 Start treatment
Step 5 Give information, instructions, and warnings
Step 6 Monitor (and stop?) treatment
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translations or local editions, at that time (2001) making the
GGP the second most-translated WHO publication (Table 1).
In 2005, Smith et al. evaluated the educational outcomes of
these training courses [9]. All 245 participants had been asked
to document their teaching practices before and after attending
the course. The number of participants who used a problem-
based approach to teach evidence-based prescribing increased
from 17% before to 80% after the course. Moreover, 75.5% of
the attendants had been able to make changes to teaching
methods and/or curricula, 92.6% of which are still in force.
A number of participants have organized courses on CPT
education in their own region.
As shown in a recent publication, 14% of European med-
ical schools use the WHO 6-step model in their curricula [10].
Of this 14%, a third (36%) are Dutch (eight) and Belgian (one)
[11]. The high use of the WHO 6-step in the Netherlands
reflects the pioneering role the country has had in the use
and evaluation of the GGP. For example, the Dutch Society
for Clinical Pharmacology and Biopharmacy organizes an an-
nual “Teach the Teachers” course based on the WHO 6-step
program as part of postgraduate training in CPT. Moreover,
Dutch and Flemish universities work together in the education
working group of the Dutch Society for Clinical
Pharmacology and Biopharmacy, which advocates the use of
a web-based prescribing learning program (P-scribe) and
which has developed a compulsory examination for final-
year medical students to assess prescribing. This so-called
“prescribing license” examination was introduced in three
Dutch medical schools in 2014 [12, 13] and will gradually
be implemented in the other Dutch and Flemish universities.
All UK medical schools have long assessed the prescribing
skills of final-year students. Collaboration between the UK
Medical Schools Council and British Pharmacological
Society led to the development of the online UK Prescribing
Safety Assessment (PSA) based on a similar (10-step) ap-
proach [14, 15]. A report described the delivery of the PSA
to all UK final-year medical students in 2016. A total of 7343
final-year medical students in all 31 UK medical schools sat
the PSA. The overall pass rate was 95% with the pass rates for
the individual papers ranging from 93 to 97% [15].
In 2006, Smith et al. reported on the development and
evaluation of a web-based interactive prescribing curriculum
for Australian senior medical students, based on the GGP [16].
The project was initiated by the National Prescribing Service
to improve the quality of prescribing education. In 2004, 9 of
11Australianmedical schools used the curriculum. In Canada,
an e-learning program combined with interprofessional co-
teaching (physician–pharmacist) based on the GGP process
of rational prescribing has been developed to support effective
prescribing in the family medicine residency program [17]. In
some medical schools in Spain, a mobile so-called p-drug app
for medical students and their teachers has been in use since
2009. This allows teachers to correct and grade students as
they choose their p-drugs and solve patient problems [18].
Lastly, Turkey has developed a postgraduate training course
(based on the GGP) to improve the rational pharmacotherapy
planning behavior of general practitioners [19]. Undoubtedly
there are many more countries where the GGP or a method
derived from it is used. Since these initiatives have not been
published (literature or internet), it is unfortunately difficult to
say anything about these local activities and developments. It
is therefore one of the goals of this publication and of the first
phase (see chapter “revision project”) to get in touch with
users around the world and learn more about their activities.
Related developments
In the past 25 years, several developments have occurred in
relation to the GGP and the TGGP and to the teaching of the 6-
step method.
Medical and prescriber education
Before the publication of the GGP, sequential learning was the
main teaching method in medical education: first gaining and
then applying knowledge. In the 1980s, problem-based teach-
ing was gradually introduced as a way to help students acquire
knowledge by solving problems; later, this approach was used
to help students acquire both knowledge and cognitive skills
(clinical and therapeutic reasoning). Nowadays, based on fur-
ther research in cognitive psychology and learning processes,
context learning is advocated as the most effective teaching
method.
Context learning is defined as learning in a setting that
is similar to that of the future profession [20]. For medical
students, this is a clinical setting. Context learning can be
implemented in various ways, i.e., from written patient
cases or role play sessions to real clinical practice. For
example, student-run clinics are a new educational con-
cept to prepare medical students for their role as prescrib-
er [21]. The clinics have been shown to provide the most
realistic setting for context-based learning while at the
same time giving students early clinical experience with
maximum responsibility for patient care [22]. As shown
recently by Schutte et al., a student-run clinic focused on
pharmacotherapy education is feasible, valuable, and of-
fers students the opportunity to learn in a real interprofes-
sional setting [23]. Furthermore, students show a high
level of intrinsic motivation to participate in these clinics
and perceive an improvement in their pharmacotherapy
competence [24]. Current knowledge about, and the rela-
tionship between, context learning, therapeutic decision-
making, and clinical practice (6-step approach), is sum-
marized in Fig. 1.
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Internet/digital support systems
Internet and mobile technology (smart phones, personal com-
puters) has enabled current and future prescribers in both HIC
(high-income countries) and LMIC countries to access vast
amounts of pharmacotherapy-related information. Moreover,
tools, such as treatment guidelines, medicine–medicine inter-
action checkers, and clinical decision support systems, have
become indispensable to prescribing practice. These digital
prescribing tools are of course a huge advance, but the prob-
lem of “alert fatigue,” [26] where prescribers ignore much of
the interaction alerts even if they are clinically relevant, shows
that digital tools can never be the only solution in terms of
medication safety. Therefore digital prescribing tools are an
increasingly important guide on the side to the process of
prescribing, but can never be a replacement for rational ther-
apeutic reasoning. Moreover, the digital revolution in pre-
scribing shifts the challenge of teaching and learning good
prescribing towards the selection and critical appraisal of in-
formation, rather than merely gaining factual knowledge. The
Internet also makes interactive (distance) education possible.
Indeed, it was recently shown that online digital learning re-
sources are important assets to many prescribing curricula,
and that they are effective in teaching the required knowledge,
skills, and attitudes [27]. The open sharing of these resources
between universities is currently being investigated as means
to harmonize and modernize prescribing education [28]. The
GGP and TGGP should use the internet potential for wide-
spread dissemination. Finally, it should not be forgotten that
digitization not only supports health professionals, but that
patients are increasingly making use of it.
Patient care/shared decision-making
Patient care has evolved in many ways. An important devel-
opment is the role of the patient, especially with regard to
increasing patient assertiveness, knowledge, and patient re-
sponsibility for their own health. Shared decision-making
(SDM) has become increasingly important in patient care.
Instead of clinicians making therapeutic decisions on behalf
of patients, clinicians and patients share the best available
evidence and possibilities about a specific treatment to reach
a shared decision [29].
Other prescribers
Until recently, in most countries, only medical practitioners
and dentists were legally licensed to prescribe medicines.
Nowadays, more professional groups, such as nurse practi-
tioners, physician assistants, and even pharmacists, are autho-
rized to prescribe (some) medicines in several countries.
Furthermore, in LMIC, it is common practice that para-
medics are in the front line of medical care. There is no reason
to suggest that the logic of GGP between medics and other
professionals is different, but their experiences might differ
and be content specific.
Medicine use
The need to promote the rational use of medicines is perhaps
greater now than it was 20 years ago. Evidence-based guide-
lines are now an accepted part of prescribing culture, and
health technology assessment often defines what is available
Fig. 1 Current understanding of
how students and junior doctors
learn to prescribe medicines can
be summarized in a composite
model based on three separate
models, namely, the normative
rational pharmacotherapeutic
process in clinical practice (WHO
6-step), therapeutic reasoning (in
experienced and non-experienced
prescribers), and contextual
learning [25]. See http://dare.
ubvu.vu.nl/handle/1871/54827
for more detailed information
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in the benefit packages and available to prescribers. Although
government funding and health insurance are increasing in
many low- and medium-income countries (LMIC’s), access
to affordable, quality-assured, safe, and effective medicines
continues to be a major challenge. It is becoming one in
wealthy countries as well, as a result of the increasing cost
of medicines and medical appliances [30]. In addition, the
increasing problem of polypharmacy, in particular in HIC’s
and MIC’s, is leading to a growing awareness of the problem
and implementation of deprescribing practices.
EACPT/IUPHAR
Last but not least, over the past 25 years, the European
Association for Clinical Pharmacology and Therapeutics
(EACPT) has evolved to become a valuable organization for
teaching CPT [31]. The Association’s biannual conferences
hold two symposia on education, and the Association supports
an active working group on CPT teaching. Two summer
schools on CPT Education have been held recently (2012
Amsterdam and 2018 Birmingham). Furthermore, the
EACPT has funded several international studies on education
since 2015 [10, 28, 32, 33]. This support has resulted in an
impressive network of universities and active teachers in
Europe (and beyond), a network which could also function
as a way to disseminate the GGP and TGGP. A similar devel-
opment occurred in the International Union of Pharmacology
and Clinical Pharmacology (IUPHAR).
Discussion, conclusions
The aim of the evaluation was to give direction to the envis-
aged updating of the GGP and TGGP and was based on in-
formation from the Internet and several other (personal)
sources. This evaluation is not complete; several local and
unpublished activities and developments may have been
missed, in particular, with respect to LMIC. However, despite
this, a number of (provisional) conclusions can still be drawn:
1. An update of the GGP and TGGP, both in terms of content
and form, is necessary after 25 years because of the cur-
rent need for these tools (irrational medicine use and un-
availability of medicines remain a problem), the lack of
similar documents, the lack of relevance with regard to
recent developments, and the possible non-optimal treat-
ment suggestions in the patient cases of both documents
that are out of date and do not reflect the prescribing
options available.
2. The basic (6-step) model of the GGP is effective in
terms of rational prescribing in the undergraduate sit-
uation. It is basically consistent with theories about
(context) learning, clinical decision-making, and
clinical practice. However, all steps need to be critical-
ly re-appraised with respect to their appropriateness
for (teaching) rational prescribing. An important focus
for the revision will be the choice of medicine (step 3a
and b). Experienced doctors have developed their own
sets of p-drugs (treatment script or evoked-set), con-
sistent with clinical decision-making theories [34, 35].
What is not known is how these treatment scripts or
sets are established [25]. Unfortunately, irrational pre-
scribing still exists despite these scripts and the avail-
ability of treatment guidelines. Other focus points will
be the choice of ineffective and expensive forms of
drug administration, such as injections, and shared de-
cision-making, including the patient’s role in his/her
health.
3. The dissemination and introduction of the GGP and
TGGP in education has been successful so far, but is still
not optimal. Lack of support and cooperation are possible
causes, as reflected by the positive effect of efforts to
overcome these barriers in countries such as Australia,
the UK, and the Netherlands with their local
“ambassadors.”
Bearing these findings in mind, the GGP and TGGP
should be revised in the broadest possible sense. This ob-
jective means that not only should their content and form
be revised, but also their dissemination and use in teaching
and assessment should be optimized (both in under- and
postgraduate setting and in continuing medical education).
This aim requires more organization, collaboration, and
coordination by “ambassadors” at local, national, and in-
ternational levels. Furthermore, the impact of the GGP and
TGGP on prescribing skills and behavior should be eval-
uated. It goes without saying that the GGP and TGGP and
the accompanying teaching materials and methods should
be easily adaptable to local needs and possibilities, in par-
ticular with respect to LMIC’s.
Revision project
On the basis of the evaluation results, we have developed a
plan for the revision of the GGP and TGGP. It consists of three
phases, which partly overlap.
In the first phase (2019/2020), the aim is to define the
ultimate goals of the GGP and TGGP and to determine what
should be changed (and what not) with respect to their content
and form. At the same time, we will review what other teach-
ing materials and prescribing guides exists, and what can be
learned from them.
We will perform an online cloud-based questionnaire
among selected teachers, (postgraduate) students, and pre-
scribers from HIC and LMIC in all 6 WHO regions. We
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invite readers of this article to participate via www.
guidetogoodprescribing.org. Where necessary, several
questionnaire rounds will be performed in order to reach
consensus. This approach will also make it possible to
identify capable revisers for phase 2. Furthermore,
preparations will be made for phase 2.
The aim of the second phase (2020/2021) is the actual
revision of the GGP and TGGP. The methodology to be used
has still to be developed. A contemporary online version will
also be developed.
In the third phase (2021/2023), the GGP and TGGPwill be
disseminated, evaluated, and optimized for use. The impact of
these guides on prescribing skills will be evaluated. All re-
viewers and writers will be closely involved in this phase. It
is still too early to provide detailed plans for this phase yet.
The project will be performed by RECIPE (Research and
Expertise Center in Pharmacotherapy Education), Department
of Internal Medicine, Amsterdam UMC, location VU
University Medical Center, in close collaboration with the
WHO. The project leaders are Ass. Prof. Jelle Tichelaar,
Ass. Prof. Milan Richir (both Amsterdam UMC), and Dr.
Sarah Garner (WHO Regional Office for Europe). Till
June 2019, Dr. Sarah Garner worked at the WHO
Headquarters in Geneva; from June 2019, her new position
is Acting Program Manager.
Health Technologies and Pharmaceuticals, Division of
Health Systems, and Public Health at the WHO Regional
Office for Europe. Relevant stakeholders such as EACPT
and IUPHAR will be asked to advise or support the project,
for example, in committees, or advisory boards or by contrib-
uting to the revision. More information: website WHO GGP
or RECIPE: www.guidetogoodprescribing.org—www.
recipeamsterdam.com
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